Still time to load your portfolio with that stock. This is still early days in the rerating of this company if the restructuring happens before the year end.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025